Meeder Asset Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-225
| Closed | -$17K | – | 2346 |
|
|
2019
Q4 | $17K | Hold |
225
| – | – | ﹤0.01% | 1405 |
|
|
2019
Q3 | $9K | Sell |
225
-30
| -12% | -$1.2K | ﹤0.01% | 1562 |
|
|
2019
Q2 | $9K | Buy |
255
+110
| +76% | +$3.88K | ﹤0.01% | 1480 |
|
|
2019
Q1 | $8K | Hold |
145
| – | – | ﹤0.01% | 1294 |
|
|
2018
Q4 | $7K | Buy |
145
+19
| +15% | +$917 | ﹤0.01% | 1328 |
|
|
2018
Q3 | $11K | Buy |
126
+72
| +133% | +$6.29K | ﹤0.01% | 1137 |
|
|
2018
Q2 | $5.65K | Buy |
54
+16
| +42% | +$1.68K | ﹤0.01% | 1246 |
|
|
2018
Q1 | $3K | Buy |
38
+4
| +12% | +$316 | ﹤0.01% | 1316 |
|
|
2017
Q4 | $5K | Sell |
34
-16
| -32% | -$2.35K | ﹤0.01% | 1303 |
|
|
2017
Q3 | $8K | Buy |
50
+33
| +194% | +$5.28K | ﹤0.01% | 1122 |
|
|
2017
Q2 | $3K | Sell |
17
-14
| -45% | -$2.47K | ﹤0.01% | 1315 |
|
|
2017
Q1 | $5K | Sell |
31
-58
| -65% | -$9.36K | ﹤0.01% | 1056 |
|
|
2016
Q4 | $19K | Buy |
+89
| New | +$19K | ﹤0.01% | 662 |
|